Hosted on MSN

Illumina's SWOT analysis: stock outlook amid sequencing market shifts

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

Illumina (ILMN): Assessing Valuation After Launch of 5-Base Sequencing and Constellation Platform Advances

Illumina (ILMN) is capturing attention following the debut of its proprietary 5-base sequencing solution and impressive results from GeneDx’s pilot of the constellation platform. Both developments ...
GEN

At ASHG, Illumina to Share Updates to Sequencing, Proteomics, and Single-Cell Technologies

During the meeting, Steve Barnard, PhD, Illumina’s CTO will provide new details about the company’s constellation mapped read technology. He will be joined by Niall Lennon, PhD, chair and CSO of Broad ...
Morningstar

Illumina launches new business to accelerate technology and data-driven discovery

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ...
FierceBiotech

JPM25: Regeneron, Illumina and more back Truveta for 10M genome sequencing project

Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf the efforts of the National Institutes of Health’s All of Us million-person program and ...
Science Daily

Machine learning algorithm brings long-read sequencing to the clinic

SAVANA uses a machine learning algorithm to identify cancer-specific structural variations and copy number aberrations in long-read DNA sequencing data. The complex structure of cancer genomes means ...